Входя на эту страницу, Вы подтверждаете, что являетесь  медицинским работником.

Status message

Not the entire site translated, but only to "Magazine"

Diagnostics and Treatment of Generalized Anxiety Disorder (Literature Review)

Moscow Research Institute of Psychiatry, branch of Serbsky National Medical Research Center for Psychiatry and Narcology, Pirogov Russian Research Medical University.

Summary. The paper reviews current publications on the epidemiology, pathogenesis, diagnostic criteria, comorbidiry and treatment of generalized anxiety disorder. The latter is widely spread in the population and general medical practice patients and results in substantial disadaptation and worse somatic health. However, to identify specific diagnostic criteria for generalized anxiety disorder and to substantiate its independence outside other disorders, mainly depressive ones, are urgent as before. Some aspects of the problem are analyzed with emphasis on pathogenetically based approaches to pharmacotherapy for generalized anxiety disorder

References: 
  • 1. Kessler R.C. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States // Arch Gen Psychiatry. – 1994. – Vol. 51, No. 1. – P. 8. – DOI: 10.1001/archpsyc.1994.03950010008002
  • 2. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National comorbidity survey replication // Arch Gen Psychiatry. – 2005. – Vol. 62, No. 6. – P. 593. – DOI: 10.1001/archpsyc.62.6.593
  • 3. Grandes G., Montoya I., Arietaleanizbeaskoa M.S., Arce V., Sanchez A. The burden of mental disorders in primary care // Eur Psychiatry. – 2011. – Vol. 26, No. 7. – P. 428–435. – DOI: 10.1016/j.eurpsy.2010.11.002
  • 4. Kessler R.C., DuPont R.L., Berglund P., Wittchen H.U. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys // Am J Psychiatry. – 1999. – DOI: 10.1176/ajp.156.12.1915
  • 5. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication // Arch Gen Psychiatry. – 2005. – Vol. 62, No. 6. – P. 617–627. – DOI: 10.1001/archpsyc.62.6.617
  • 6. Lieb R., Becker E., Altamura C. The epidemiology of generalized anxiety disorder in Europe // Eur Neuropsychopharmacol. – 2005. – Vol. 15, No. 4. – P. 445–452. – DOI: 10.1016/j.euroneuro.2005.04.010
  • 7. Weisberg R.B. Overview of generalized anxiety disorder // J Clin Psychiatry. – 2009. – Vol. 70, No. 2. – P. 4–9. – DOI: 10.4088/jcp.s.7002.01
  • 8. Rubio G., López-Ibor J.J. Generalized anxiety disorder: a 40-year follow-up study // Acta Psychiatr. Scand. – 2007. – Vol. 115, No. 5. – P. 372–379. – DOI: 10.1111/j.1600-0447.2006.00896.x
  • 9. Leon A.C. Prevalence of mental disorders in primary care. Implications for screening // Arch Fam Med. – 1995. – Vol. 4, No. 10. – P. 857–861. – DOI: 10.1001/archfami.4.10.857
  • 10. Olfson M., Fireman B., Weissman M.M., Leon A.C., Sheehan D.V, Kathol R.G., Hoven C., Farber L. Mental disorders and disability among patients in a primary care group practice // Am J Psychiatry. – 1997. – Vol. 154, No. 12. – P. 1734–1740. – DOI: 10.1176/ajp.154.12.1734
  • 11. Rodriguez B.F., Weisberg R.B., Pagano M.E., Bruce S.E., Spencer M.A., Culpepper L., Keller M.B. Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patients // J Nerv Ment Dis. – 2006. – Vol. 194, No. 2. – P. 91–97. – DOI: 10.1097/01.nmd.0000198140.02154.32
  • 12. Roy-Byrne P.P., Wagner A. Primary care perspectives on generalized anxiety disorder // J Clin Psychiatry. – 2004. – Vol. 65, No.13. – P. 20–26.
  • 13. Mental illness in general health care: an international study / ed. T.B. Üstün, N. Sartorius. – John Wiley & Sons, 1995.
  • 14. Vel'tishchev D.Yu., Marchenko A.S. Generalizovannoe trevozhnoe rasstrojstvo: problemy diagnostiki, prognoza i psihofarmakoterapii // Sovremennaya terapiya psihicheskih rasstrojstv. – 2013. – № 1. – C. 17–23.
  • 15. Angst J., Gamma A., Baldwin D.S., Ajdacic-Gross V., Rössler W. The generalized anxiety spectrum: Prevalence, onset, course and outcome // Eur Arch Psychiatry Clin Neurosci. – 2009. – DOI: 10.1007/s00406-008-0832-9
  • 16. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., June Ruan W., Goldstein R.B., Smith S.M., Saha T.D., Huang B. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions // Psychol Med. – 2005. – Vol. 35, No. 12. – P. 1747–1759. – DOI: 10.1017/S0033291705006069
  • 17. Neznanov N.G., Martynihin I.A., Mosolov S.N. Diagnostika i terapiya trevozhnyh rasstrojstv v Rossijskoj Federacii: rezul'taty oprosa vrachej-psihiatrov // Sovremennaya terapiya psihicheskih rasstrojstv. – 2017. – № 2. – S. 2–13.
  • 18. Reed G.M., Correia J.M., Esparza P., Saxena S., Maj M. The WPA‐WHO global survey of psychiatrists’ attitudes towards mental disorders classification // World Psychiatry. – 2011. – Vol. 10, No. 2. – P. 118–131.
  • 19. Mosolov S.N. Trevozhnye i depressivnye rasstrojstva (komorbidnost' i terapiya). – M.: Artinfo Pablishing, 2007. – 63 s.
  • 20. Vertogradova O.P. Vozmozhnye podhody k tipologii depressij // Depressiya (psihopatologiya, patogenez) // Trudy Moskovskogo NII psihiatrii. –1980. – T. 91. – C. 9–16.
  • 21. Newman M.G., Llera S.J., Erickson T.M., Przeworski A., Castonguay L.G. Worry and generalized anxiety disorder: A review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment // Annu Rev Clin Psychol Annual Reviews. – 2013. – Vol. 9, No. 1. – P. 275–297. – DOI: 10.1146/annurev-clinpsy-050212-185544
  • 22. Pluess M., Conrad A., Wilhelm F.H. Muscle tension in generalized anxiety disorder: A critical review of the literature // J Anxiety Disord. – 2009. – Vol. 23, No. 1. – P. 1–11. – DOI: 10.1016/j.janxdis.2008.03.016
  • 23. Golland V.B., Dmitrieva T.B., Kazakovcev B.A. Psihicheskie rasstrojstva i rasstrojstva povedeniya (F00-F99).(Klass V MKB-10, adaptirovannyj dlya ispol'zovaniya v Rossijskoj Federacii). / Pod red. B.A. Kazakovceva, V.B. Gollanda. – M.: Prometej, 2013. – 584 s.
  • 24. American Psychiatric Association. DSM 5 // American Journal of Psychiatry. – 2013. – DOI: 10.1176/appi.books.9780890425596.744053.
  • 25. Wittchen H.-U., Kessler R.C., Beesdo K., Krause P., Höfler M., Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management // J Clin Psychiatry. – 2002. – Vol. 63, Suppl 8. – P. 24–34.
  • 26. Ramsawh H.J., Stein M.B., Belik S.-L., Jacobi F., Sareen J. Relationship of anxiety disorders, sleep quality, and functional impairment in a community sample // J Psychiatr Res. – 2009. – Vol. 43, No. 10. – P. 926–933. – DOI: 10.1016/j.jpsychires.2009.01.009
  • 27. Wittchen H.-U. Generalized anxiety disorder: prevalence, burden, and cost to society // Depress Anxiety. – 2002. – Vol. 16, No. 4. – P. 162–171. – DOI: 10.1002/da.10065
  • 28. Buhr K., Dugas M.J. Investigating the construct validity of intolerance of uncertainty and its unique relationship with worry // J Anxiety Disord. – 2006. – DOI: 10.1016/j.janxdis.2004.12.004
  • 29. Yonkers K.A., Dyck I.R., Warshaw M., Keller M.B. Factors predicting the clinical course of generalised anxiety disorder // Br J Psychiatry. – 2000. – Vol. 176. – P. 544–549.
  • 30. Yonkers K.A., Bruce S.E., Dyck I.R., Keller M.B. Chronicity, relapse, and illness? Course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow-up // Depress Anxiety. – 2003. – Vol. 17, No. 3. – P. 173–179. – DOI: 10.1002/da.10106
  • 31. Wittchen H.-U., Hoyer J., Friis R. Generalized anxiety disorder – a risk factor for depression? // Int J Methods Psychiatr Res. – 2001. – Vol. 10, No. 1. – P. 52–57. – DOI: 10.1002/mpr.100
  • 32. Alegría A.A., Hasin D.S., Nunes E. V, Liu S.-M., Davies C., Grant B.F., Blanco C. Comorbidity of generalized anxiety disorder and substance use disorders: results from the National epidemiologic survey on alcohol and related conditions // J Clin Psychiatry. – 2010. – Vol. 71, No. 9. – P. 1187–95; quiz 1252-3. – DOI: 10.4088/JCP.09m05328gry
  • 33. Greenberg P.E., Sisitsky T., Kessler R.C., Finkelstein S.N., Berndt E.R., Davidson J.R.T., Ballenger J.C., Fyer A.J. The economic burden of anxiety disorders in the 1990s // J Clin Psychiatry. – 1999. – DOI: 10.4088/JCP.v60n0702
  • 34. Stein M.B., Heimberg R.G. Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample // J Affect Disord. – 2004. – Vol. 79, No. 1–3. – P. 161–166. – DOI: 10.1016/s0165-0327(02)00457-3
  • 35. Hoffman D.L., Dukes E.M., Wittchen H.-U. Human and economic burden of generalized anxiety disorder // Depress Anxiety. – 2008. – Vol. 25, No. 1. – P. 72–90. – DOI: 10.1002/da.20257
  • 36. Sareen J., Cox B.J., Afifi T.O., de Graaf R., Asmundson G.J.G., ten Have M., Stein M.B. Anxiety disorders and risk for suicidal ideation and suicide attempts // Arch Gen Psychiatry. – 2005. – Vol. 62, No. 11. – P. 1249. – DOI: 10.1001/archpsyc.62.11.1249
  • 37. Boden J.M., Fergusson D.M., Horwood L.J. Anxiety disorders and suicidal behaviours in adolescence and young adulthood: Findings from a longitudinal study // Psychol Med. – 2007. – DOI: 10.1017/S0033291706009147
  • 38. Kennedy B.L., Schwab J.J. Utilization of medical specialists by anxiety disorder patients // Psychosomatics. – 1997. – Vol. 38, No. 2. – P. 109–112. – DOI: 10.1016/s0033-3182(97)71478-6
  • 39. Harter M.C., Conway K.P., Merikangas K.R. Associations between anxiety disorders and physical illness // Eur Arch Psychiatry Clin Neurosci. – 2003. – Vol. 253, No. 6. – P. 313–320. – DOI: 10.1007/s00406-003-0449-y
  • 40. Roy-Byrne P.P., Davidson K.W., Kessler R.C., Asmundson G.J.G., Goodwin R.D., Kubzansky L., Lydiard R.B., Massie M.J., Katon W., Laden S.K., Stein M.B. Anxiety disorders and comorbid medical illness // Gen Hosp Psychiatry. – 2008. – Vol. 30, No. 3. – P. 208–225. – DOI: 10.1016/j.genhosppsych.2007.12.006
  • 41. Martens E.J., de Jonge P., Na B., Cohen B.E., Lett H., Whooley M.A. Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease // Arch Gen Psychiatry. – 2010. – Vol. 67, No. 7. – P. 750. – DOI: 10.1001/archgenpsychiatry.2010.74
  • 42. Barger S.D., Sydeman S.J. Does generalized anxiety disorder predict coronary heart disease risk factors independently of major depressive disorder? // J Affect Disord. – 2005. – DOI: 10.1016/j.jad.2005.05.012
  • 43. Carrière I., Ryan J., Norton J., Scali J., Stewart R., Ritchie K., Ancelin M.L. Anxiety and mortality risk in community-dwelling elderly people // Br J Psychiatry. – 2013. – Vol. 203, No. 4. – P. 303–309. – DOI: 10.1192/bjp.bp.112.124685
  • 44. Remes O., Wainwright N., Surtees P., Lafortune L., Khaw K.T., Brayne C. Generalized anxiety disorder and excess cancer deaths: findings from a large, longitudinal study // Eur Neuropsychopharmacol. – 2016. – Vol. 26. – P. S598. – DOI: 10.1016/s0924-977x(16)31673-x
  • 45. Judd L.L., Kessler R.C., PauIus M.P., Zeller P. V, Wittchen H.-U., Kunovac J.L. Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS) // Acta Psychiatr Scand. – 1998. – Vol. 98, No. s393. – P. 6–11. – DOI: 10.1111/j.1600-0447.1998.tb05960.x
  • 46. Bruce S.E., Yonkers K.A., Otto M.W., Eisen J.L., Weisberg R.B., Pagano M., Shea M.T., Keller M.B. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study // Am J Psychiatry. – 2005. – DOI: 10.1176/appi.ajp.162.6.1179
  • 47. Moffitt T.E., Harrington H.L., Caspi A., Kim-Cohen J., Goldberg D., Gregory A.M., Poulton R. Depression and generalized anxiety disorder: Cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years // Arch Gen Psychiatry. – 2007. – DOI: 10.1001/archpsyc.64.6.651
  • 48. Skre I., Onstad S., Edvardsen J., Torgersen S., Kringlen E. A family study of anxiety disorders: familial transmission and relationship to mood disorder and psychoactive substance use disorder // Acta Psychiatr Scand. – 1994. – Vol. 90, No. 5. – P. 366–374. – DOI: 10.1111/j.1600-0447.1994.tb01608.x
  • 49. Mendlewicz J., Papadimitriou G., Wilmotte J. Family study of panic disorder: Comparison with generalized anxiety disorder, major depression and normal subjects // Psychiatr Genet. – 1993. – Vol. 3, No. 2. – P. 73–78. – DOI: 10.1097/00041444-199322000-00002
  • 50. Moffitt T.E., Caspi A., Harrington H., Milne B.J., Melchior M., Goldberg D., Poulton R. Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to age 32 // Psychol Med. – 2007. – Vol. 37, No. 3. – P. 441–452. – DOI: 10.1017/S0033291706009640
  • 51. Spitzer R.L., Kroenke K., Williams J.B.W., Löwe B. A brief measure for assessing generalized anxiety disorder // Arch Intern Med. – 2006. – Vol. 166, No. 10. – P. 1092. – DOI: 10.1001/archinte.166.10.1092
  • 52. Löwe B., Decker O., Müller S., Brähler E., Schellberg D., Herzog W., Herzberg P.Y. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population // Med Care. – 2008. – Vol. 46, No. 3. – P. 266–274. – DOI: 10.1097/mlr.0b013e318160d093
  • 53. Kroenke K., Spitzer R.L., Williams J.B.W., Monahan P.O., Löwe B. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection // Ann Intern Med. – 2007. – Vol. 146, No. 5. – P. 317. – DOI: 10.7326/0003-4819-146-5-200703060-00004
  • 54. NICE: Generalised anxiety disorder and panic disorder in adults: management. – Clinical guideline, 2017. – URL: https://www.nice.org.uk/guidance/cg113 (accessed 12 May 2018).
  • 55. Mosolov S.N., Alfimov P.V. Algoritm biologicheskoj terapii generalizovannogo trevozhnogo rasstrojstva // Sovremennaya terapiya psihicheskih rasstrojstv. – 2015. – № 2. – S. 24–28.
  • 56. Bandelow B., Zohar J., Hollander E., Kasper S., Möller H.J., Allgulander C., Ayuso-Gutierrez J., Baldwin D.S., Bunevicius R., Cassano G., Fineberg N., Gabriels L., Hindmarch I., Kaiya H., Klein D.F., Lader M., Lecrubier Y., Lépine J.P., Liebowitz M.R., Lopez-Ibor J.J., Marazziti D., Miguel E.C., Oh K.S., Preter M., Rupprecht R., Sato M., Starcevic V., Stein D.J., van Ameringen M., Vega J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – First revision // World J Biol Psychiatry. – 2008. – DOI: 10.1080/15622970802465807
  • 57. Ballenger J.C., Davidson J.R., Lecrubier Y., Nutt D.J., Borkovec T.D., Rickels K., Stein D.J., Wittchen H.U. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety // J Clin Psychiatry. – 2001. – Vol. 62, Suppl. 1. – P. 53–58.
  • 58. Davidson J., Zhang W., Connor K., Ji J., Jobson K., Lecrubier Y., McFarlane A., Newport D., Nutt D., Osser D., Stein D., Stowe Z., Tajima O., Versiani M. A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD) // J Psychopharmacol. – 2010. – Vol. 24, No 1. – P. 3–26. – DOI: 10.1177/0269881108096505
  • 59. Davidson J.R.T. First-line pharmacotherapy approaches for generalized anxiety disorder // J Clin Psychiatry. – 2009. – Vol. 70, № 2. – P. 25–31. – DOI: 10.4088/JCP.s.7002.05
  • 60. Montgomery S.A., Tobias K., Zornberg G.L., Kasper S., Pande A.C. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder // J Clin Psychiatry. – 2006. – Vol. 67, No. 05. – P. 771–782. – DOI: 10.4088/jcp.v67n0511
  • 61. Montgomery S.A., Herman B.K., Schweizer E., Mandel F.S. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia // Int Clin Psychopharmacol. – 2009. – Vol. 24, No. 4. – P. 214–222. – DOI: 10.1097/YIC.0b013e32832dceb9
  • 62. Kavoussi R. Pregabalin: From molecule to medicine // Eur Neuropsychopharmacol. – 2006. – Vol. 16. – P. S128–S133. – DOI: 10.1016/j.euroneuro.2006.04.005
  • 63. Feltner D., Wittchen H.U., Kavoussi R., Brock J., Baldinetti F., Pande A.C. Long-term efficacy of pregabalin in generalized anxiety disorder // Int Clin Psychopharmacol. – 2008. – Vol. 23, No. 1. – P. 18–28. – DOI: 10.1097/YIC.0b013e3282f0f0d7
  • 64. Owen R.T. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety // Drugs Today (Barc). – 2007. – Vol. 43, No. 9. – P. 601–610. – DOI: 10.1358/dot.2007.43.9.1133188
  • 65. Pohl R.B., Feltner D.E., Fieve R.R., Pande A.C. Efficacy of Pregabalin in the Treatment of Generalized Anxiety Disorder // J Clin Psychopharmacol. – 2005. – Vol. 25, No. 2. – P. 151–158. – DOI: 10.1097/01.jcp.0000155820.74832.b0
  • 66. Rickels K., Pollack M.H., Feltner D.E., Lydiard R.B., Zimbroff D.L., Bielski R.J., Tobias K., Brock J.D., Zornberg G.L., Pande A.C. Pregabalin for treatment of generalized anxiety disorder // Arch Gen Psychiatry. – 2005. – Vol. 62, No. 9. – P. 1022. – DOI: 10.1001/archpsyc.62.9.1022.
  • 67. Smith W., Feltner D., Kavoussi R. Pregabalin in generalized anxiety disorder: Long term efficacy and relapse prevention // Eur Neuropsychopharmacol. – 2002. – Vol. 12. – P. 350. – DOI: 10.1016/s0924-977x(02)80555-7
  • 68. Khan A., Farfel G.M., Brock J.D. Efficacy and safety of pregabalin for the treatment of GAD in elderly patients. – Toronto: Ann. Meeting of APA, 2006. – P. 283–284.
  • 69. Hindmarch I., Trick L., Ridout F. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers // Psychopharmacology. – 2005. – Vol. 183, No. 2. – P. 133–143. – DOI: 10.1007/s00213-005-0172-7
  • 70. Lydiard B. P.3.055 Efficacy of pregablin in treating psychic and somatic symptoms in generalized anxiety disorder (GAD) // Eur Neuropsychopharmacol. – 2003. – Vol. 13. – P. S377. – DOI: 10.1016/s0924-977x(03)92175-4
  • 71. Montgomery S.A. Pregabalin for the treatment of generalised anxiety disorder // Expert Opin Pharmacother. – 2006. Vol. 7, No. 15. – P. 2139–2154. – DOI: 10.1517/14656566.7.15.2139
  • 72. Pande A.C., Crockatt J.G., Janney C., Feltner D.E. FC04.04 Pregabalin treatment of generalised anxiety disorder (GAD); three randomised, placebo controlled trials // Eur Psychiatry. – 2000. – Vol. 15. – P. s244. – DOI: 10.1016/s0924-9338(00)94047-1